Management of Rheumatoid Arthritis in the Janus Kinase (JAK) Inhibitors Era

Countless people globally endure the challenges of rheumatoid arthritis, a persistent inflammatory condition leading to pain, swelling, and joint issues. A significant shift in rheumatology occurred with the introduction of Janus Kinase (JAK) inhibitors, bringing about transformative changes. Rheumatoid arthritis is an auto-immune disorder that causes chronic inflammation affecting many joints, including hands and feet.